Chu‐Bin Luo
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Surgery 8
- Cholangiocarcinoma and Gallbladder Cancer Studies 8
-
- RNA modifications and cancer 4
- Circular RNAs in diseases 2
- Co-authors
- Shao‐Lai Zhou (21 shared papers)Zheng‐Jun Zhou (21 shared papers)Zhiqiang Hu (20 shared papers)Haoyang Xin (17 shared papers)Jia Fan (17 shared papers)Xiaowu Huang (12 shared papers)Jian Zhou (8 shared papers)Ya Cao (4 shared papers)
- Journals
- Hepatology (5 papers)Cancer Immunology Immunotherapy (2 papers)Signal Transduction and Targeted Therapy (1 paper)npj Genomic Medicine (1 paper)Journal for ImmunoTherapy of Cancer (1 paper)
- Partner nations
- ChinaEthiopiaUnited States
In The Last Decade
Chu‐Bin Luo
26 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 67
- Cancer Research 333
- Hepatology 85
- Immunology 220
- Oncology 238
- Molecular Biology 437
Countries citing papers authored by Chu‐Bin Luo
This map shows the geographic impact of Chu‐Bin Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chu‐Bin Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chu‐Bin Luo more than expected).
Fields of papers citing papers by Chu‐Bin Luo
This network shows the impact of papers produced by Chu‐Bin Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chu‐Bin Luo. The network helps show where Chu‐Bin Luo may publish in the future.
Co-authors
The 25 scholars most cited alongside Chu‐Bin Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 184 | |
| 2 | 2019 | 169 | |
| 3 | 2021 | 102 | |
| 4 | 2022 | 82 | |
| 5 | 2019 | 56 | |
| 6 | 2019 | 53 | |
| 7 | 2021 | 43 | |
| 8 | 2018 | 42 | |
| 9 | 2021 | 37 | |
| 10 | 2016 | 37 | |
| 11 | 2020 | 32 | |
| 12 | 2022 | 25 | |
| 13 | 2020 | 23 | |
| 14 | 2016 | 21 | |
| 15 | 2019 | 17 | |
| 16 | 2020 | 15 | |
| 17 | 2017 | 14 | |
| 18 | 2021 | 13 | |
| 19 | 2021 | 12 | |
| 20 | 2024 | 10 |
About Chu‐Bin Luo
Chu‐Bin Luo is a scholar working on Surgery, Molecular Biology, Immunology, Oncology and Cancer Research, having authored 26 papers that have together received 1.0k indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers), Cancer Immunotherapy and Biomarkers (4 papers), RNA modifications and cancer (4 papers), Ferroptosis and cancer prognosis (2 papers), Cancer Genomics and Diagnostics (2 papers), Immunotherapy and Immune Responses (2 papers), Circular RNAs in diseases (2 papers) and Immune cells in cancer (2 papers). The work is most often cited by research in Cancer Research (333 citations), Hepatology (85 citations), Immunology (220 citations), Oncology (238 citations) and Molecular Biology (437 citations). Chu‐Bin Luo has collaborated with scholars based in China, Ethiopia and United States. Frequent co-authors include Shao‐Lai Zhou, Zheng‐Jun Zhou, Zhiqiang Hu, Haoyang Xin, Jia Fan, Xiaowu Huang, Jian Zhou, Ya Cao, Jian Zhou and Rongqi Sun. Their work appears in journals such as Hepatology, Cancer Immunology Immunotherapy, Signal Transduction and Targeted Therapy, npj Genomic Medicine and Journal for ImmunoTherapy of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.